# Acumen Pharmaceuticals, Inc. — Form D

Acumen Pharmaceuticals, Inc. of LIVERMORE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2013-05-15. The offering totals $700K, of which $700K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2013-05-15
- Form: D
- Accession: 0001576885-13-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $700K
- Amount sold: $700K
- Investors: 8
- Date of first sale: 2013-04-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-196499

## Issuer

- Name: Acumen Pharmaceuticals, Inc.
- CIK: 0001576885
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 4435 NORTH FIRST STREET, SUITE 360, LIVERMORE, CA, 94551
- Phone: 925-368-8508

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| Franz Hefti | Director | San Diego, CA |
| Grant Krafft | Director | Livermore, CA |
| Mark Lampert | Director | Livermore, CA |
| Daniel J O'Connell | Director | West Allis, WI |
| David W Summa | Director | Livermore, CA |
| Jurgen W Weber | Director | Livermore, CA |
| William F Goure | Executive Officer | Livermore, CA |
| Daniel J O'Connell | Executive Officer | West Allis, WI |
| Franz Hefti | Promoter | San Diego, CA |

## More

- [CIK 1576885 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1576885&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001576885-13-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.